TDAC Translational Development Acquisition Corp.

Financial Services

$10.64-0.19%ClosedMarket Cap: $233.1M

As of 2026-05-25

Valuation

P/E (TTM)

36.50

PEG

0.00

P/B

1.04

P/S

0.00

EV/EBITDA

-265.94

DCF Value

—

FCF Yield

-0.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3.6%

ROA

3.4%

ROIC

-0.5%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 null	$0.00	NaN%	$-281.2K	$1.3M	$—	—
Q4 null	$0.00	NaN%	$-162.3K	$1.6M	$—	—
FY null	$0.00	NaN%	$-944.5K	$6.4M	$—	—
Q3 null	$0.00	NaN%	$-213.7K	$1.7M	$—	—
Q2 null	$0.00	NaN%	$-221.1K	$1.6M	$—	—
Q1 null	$0.00	NaN%	$-347.4K	$1.5M	$—	—
Q4 null	$0.00	NaN%	$-133.4K	$-8.0K	$—	—
FY null	$1.1M	69.9%	$-196.4K	$-71.0K	$—	—
Q3 null	$0.00	NaN%	$-61.3K	$-61.3K	$—	—
Q2 null	$0.00	NaN%	$-843.00	$-843.00	$—	—
Q1 null	$0.00	NaN%	$-843.00	$-843.00	$—	—
Q4 2023	$0.00	NaN%	$-483.8K	$-483.8K	$-0.12	—